Pre-operative factors indicating risk of multiple operations versus a single operation in women undergoing surgery for screen detected breast cancer

Breast

Volumn 22, Issue 1, 2013, Pages 78-82

  O'Flynn, E A M ^a   Currie, R J ^b   Mohammed, K ^a   Allen, S D ^a   Michell, M J ^c  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b ROYAL DEVON AND EXETER NHS FOUNDATION TRUST   (United Kingdom)

^c KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Ductal carcinoma in situ; Lobular carcinoma; Microcalcification; Reoperation

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CALCIFICATION; BREAST CARCINOMA; CANCER GRADING; CANCER INVASION; CANCER SCREENING; FEMALE; HUMAN; INTRADUCTAL CARCINOMA; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTECTOMY; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REOPERATION; RISK ASSESSMENT; SURGICAL APPROACH; SURGICAL RISK; TREATMENT PLANNING; TUMOR BIOPSY; TUMOR VOLUME; WIDE EXCISION; WOMEN'S HEALTH;

EID: 84871716447     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2012.06.011     Document Type: Article

References (21)

1. 2010. Ref type: generic. http://cancerscreening.org.uk/breastscreen/publications/baso2009-2010.pdf.
2. Waljee J.F., Hu E.S., Newman L.A., Alderman A.K. Predictors of re-excision among women undergoing breast conserving surgery for cancer. Ann Surg Oncol 2008, 15(5):1297-1303.
3. Fisher B., Redmond C., Poisson R., Margolese R., Wolmark N., Wickerham L., et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1989, 320(13):822-828.
4. Fisher B., Jeong J.H., Anderson S., Bryant J., Fisher E.R., Wolmark N. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 2002 Aug, 347(8):567-575.
5. Blichert-Toft M., Smola M.G., Cataliotti L., O'Higgins N. Principles and guidelines for surgeons-management of symptomatic breast cancer. European society of surgical oncology. Eur J Surg Oncol 1997, 23(2):101-109.
6. Smitt M.C., Horst K. Association of clinical and pathological variables with lumpectomy surgical margin status after preoperative diagnosis or excisional biopsy of invasive breast cancer. Ann Surg Oncol 2007, 14(3):1040-1044.
7. Beron P.J., Horwitz E.M., Martinez A.A., Wimbish K.J., Levine A.J., Gustafson G., et al. Pathologic and mammographic findings predicting the adequacy of tumor excision before breast-conserving therapy. AJR Am J Roentgenol 1996, 167(6):1409-1414.
8. Maxwell A.J., Ridley N.T., Rubin G., Wallis M.G., Gilbert F.J., Michell M.J. The Royal College of Radiolgists breast group breast imaging classification. Clin Radiol 2009, 10.1016/j.crad.2009.01.010.
9. Swain S.M., Sorace R.A., Bagley C.S., Danforth D.N., Bader J., Wesley M.N., et al. Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer. Cancer Res 1987, 47(14):3889-3894.
10. Perez C.A. Breast conservation therapy in patients with stage T1-T2 breast cancer: current challenges and opportunities. Am J Clin Oncol 2010, 33(5):500-510.
11. Gooiker G.A., Veerbeen I., van der Geest L.G., Stijnen T., Dekker JW., Nortier J.W., et al. The quality indicator 'tumour positive surgical margin following breast-conserving surgery' does not provide transparent insight into care. Ned Tijdschr Geneeskd 2010, 154:A1142.
12. Keskek M., Kothari M., Ardehali B., Betambeau N., Nasiri N., Gui G.P. Factors predisposing to cavity margin positivity following conservation surgery for breast cancer. Eur J Surg Oncol 2004, 30(10):1058-1064.
13. Ramanah R., Pivot X., Sautiere J.L., Maillet R., Riethmuller D. Predictors of re-excision for positive or close margins in breast-conservation therapy for pT1 tumors. Am J Surg 2008, 195(6):770-774.
14. Kuhl C.K., SHrading S., Bieling H.B., Wardelmann E., Leutner C.C., Koenig R., et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet 2007, 370(9586):485-492.
15. O'Flynn E.A., Morel J.C., Gonzalez J., Dutt N., Evans D., Wasan R. Prediction of the presence of invasive disease from the measurement of extent of malignant microcalcification on mammography and ductal carcinoma in situ grade at core biopsy. Clin Radiol 2009, 64(2):178.
16. Wahedna Y, Evans AJ, Pinder SE, Ellis IO, Blamey RW, Geraghty JG. Mammographic size of ductal carcinoma in situ does not predict the presence of an invasive.
17. Krecke K.N., Gisvold J.J. Invasive lobular carcinoma of the breast: mammographic findings and extent of disease at diagnosis in 184 patients. AJR Am J Roentgenol 1993, 161(5):957-960.
18. Dall B.J., Vinnecombe S., Gilbert F.J. Reporting and management of breast lesions detected using MRI. Clin Radiol 2011, 66(12):1120-1128.
19. Turnbull L., Brown S., Harvey I., Olivier C., Drew P., Napp V., et al. Multicentre randomised controlled trial examining the cost-effectiveness of contrast-enhanced high field magnetic resonance imaging in women with primary breast cancer scheduled for wide local excision (COMICE). Lancet 2010, 375(9714):563-571.
20. Peters N.H., van Esser S., van den Bosch M.A., Storm R.K., Plaisier P.W., van Dalen T., et al. Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET randomised controlled trial. Eur J Cancer 2011, 47(6):879-886.
21. Bloom H.J., Richardson W.W., Harries E.J. Natural history of untreated breast cancer (1805-1933). Comparison of untreated and treated cases according to histological grade of malignancy. Br Med J 1962 Jul 28, 2(5299):213-221.